Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2010-12-22
2011-11-29
Chandra, Gyan (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S329000, C530S387900, C530S391300
Reexamination Certificate
active
08067545
ABSTRACT:
The present invention relates to methods and compositions containing novel leptin peptides, preferably for the modulation of body mass (i.e., weight), more specifically for novel diagnostic and therapeutic applications in homeostasis of body weight and adipose tissue mass.
REFERENCES:
patent: 4737323 (1988-04-01), Martin et al.
patent: 4837028 (1989-06-01), Allen
patent: 4946778 (1990-08-01), Ladner et al.
patent: 4980286 (1990-12-01), Morgan et al.
patent: 5225539 (1993-07-01), Winter
patent: 5521283 (1996-05-01), DiMarchi et al.
patent: 5532336 (1996-07-01), DiMarchi et al.
patent: 5935810 (1999-08-01), Friedman et al.
patent: 6309853 (2001-10-01), Friedman et al.
patent: 2292382 (1996-02-01), None
patent: WO-9206180 (1992-04-01), None
patent: WO-9314188 (1993-07-01), None
patent: WO-9320221 (1993-10-01), None
patent: WO-9408598 (1994-04-01), None
patent: WO-9605309 (1996-02-01), None
patent: WO-9623815 (1996-08-01), None
patent: WO-9634885 (1996-11-01), None
patent: WO-9702004 (1997-01-01), None
patent: WO-9715322 (1997-05-01), None
patent: WO-9726335 (1997-07-01), None
patent: WO-9727286 (1997-07-01), None
patent: WO-9746585 (1997-12-01), None
patent: WO-9748419 (1997-12-01), None
patent: WO-9806752 (1998-02-01), None
patent: WO-9812224 (1998-03-01), None
patent: WO-9817626 (1998-04-01), None
patent: WO-9818486 (1998-05-01), None
patent: WO-9824896 (1998-06-01), None
patent: WO-9836763 (1998-08-01), None
patent: WO-9848831 (1998-11-01), None
patent: WO-9855139 (1998-12-01), None
patent: WO-9923493 (1999-05-01), None
Aubry et al., “N-Methyl Peptides. IV. Water and β-Turn in Peptides”,Int. J. Pept. Protein Res., 18:195-202 (1981).
Bach et al., “Dehydrophenylalanine Can Occur in Various Reverse-Turn Sites: Conformational Analysis of ΔPhe-Containing Model Peptides”,Biopolymers, 25:S175-S191 (1986).
Banks et al., “Leptin Enters the Brain by a Saturable System Independent of Insulin”,Peptides, 17(2):305-311 (1996).
Barash et al., “Leptin is a Metabolic Signal to the Reproductive System”,Endocrinol., 137(7):3144-3147 (1996).
Baumann et al., “The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors”,Proc. Natl. Acad. Sci. U.S.A., 93:8374-8378 (1996).
Boesen et al., “Circumvention of chemotherapy-induced myelosuppression by transfer of the mdrl gene”,Biotherapy, 6(4):291-302 (1993).
Bogardus et al., “Increased Resting Metabolic Rates in Obese Subjects with Non-insulin-dependent Diabetes Mellitus and the Effect of Sulfonylurea Therapy”,Diabetes, 35:1-5 (1986).
Bryan, W. M., “Design of Minimum Active Fragments of Biologically Active Peptides”,Meth. Enzymol., 202:436-448 (1991).
Campfield et al., “Recombinant Mouse OB Protein: Evidence for a Peripheral Signal Linking Adiposity and Central Neural Networks”,Science, 269(5223):546-549 (1995).
Capecchi et al., “Altering the Genome by Homologous Recombination”,Science, 244:1288-1292 (1989).
Caro et al., “Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance”,Lancet, 348:159-161 (1996).
Chehab et al., “Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin”,Nature Genet., 12:318-320 (1996).
Chen et al., “Evidence That the Diabetes Gene Encodes the Leptin Receptor: Identification of a Mutation in the Leptin Receptor Gene indb/dbMice”,Cell, 84:491-495 (1996).
Chou et al., “Prediction of Protein Conformation”,Biochem., 13(2):222-245 (1974).
Cioffi et al., “Novel B219/OB receptor isoforms: Possible role of leptin in hematopoiesis and reproduction”,Nature Med., 2(5):585-589 (1996).
Clement et al., “Indication for Linkage of the HumanOBGene Region With Extreme Obesity”,Diabetes, 45:687-690 (1996).
Cole et al., “The EBV-Hybridoma Technique and its Application to Human Lung Cancer”, inMonoclonal Antibodies and Cancer Therapy, Alan R. Liss, Inc., pp. 77-96 (1985).
Considine et al., “Evidence Against Either a Premature Stop Codon or the Absence of Obese Gene mRNA in Human Obesity”,J. Clin. Invest., 95(6):2986-2968 (1995).
Considine et al., “Mutation Screening and Identification of a Sequence Variation in the HumanOBGene Coding Region”,Biochem. Biophys. Res. Commun., 220:735-739 (1996).
Considine et al., “Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans”,N. Engl. J. Med., 334:292-295 (1996).
Cote et al., “Generation of human monoclonal antibodies reactive with cellular antigens”,Proc. Natl. Acad. Sci. U.S.A., 80:2026-2030 (1983).
DeGrado, W. F., “Design of Peptides and Proteins”,Adv. Protein Chem., 39:51-124 (1988).
Doherty et al., “Structure-Activity Relationships of C-Terminal Endothelin Hexapeptide Antagonists”,J. Med. Chem., 36(18):2585-2594 (1993).
Engstrom, A., “The Arrangement of the Protein Molecules in Nuclear-Polyhedrosis Inclusions”,Biochem. Exp. Biol., 11:7-13 (1974).
Fauchere et al., “Evaluation of the Stability of Peptides and Pseudopeptides as a Tool in Peptide Drug Design”,Adv. Drug Res., 23:127-159 (1992).
Fruhbeck et al., “Age-related differences in the thermogenic and ponderal effects following the administration of fragment peptides from the ratobprotein”,Regulatory Peptides, 73(2):83-87 (1998).
Fruhbeck et al., “Leptin: physiology and pathophysiology”,Clin. Physiol., 18:399-419 (1998).
GenBank Accession No. AF098792, Feb. 8, 1999.
GenBank Accession No. U22421, Mar. 23, 1995.
GenBankAccession No. NM—000230, Aug. 16, 2009.
Ghilardi et al., “Defective STAT signaling by the leptin receptor indiabeticmice”,Proc. Natl. Acad. Sci; . U.S.A., 93(13):6231-6235 (1996).
Goldspiel et al., “Human gene therapy”,Clin. Pharm., 12:488-505 (1993).
Gonzalez et al., “Effect of acute immunoneutralization of endogenous leptin on prolactin an LH secretion during the afternoon of pro-oestrus or in steroid-treated ovariectomized female rats”,J. Rep. Fert., 118:39-45 (2000).
Gonzalez et al., “Leptin116-130Stimulates Prolactin and Luteinizing Hormone Secretion in Fasted Adult Male Rats”,Neuroendocrinol., 70:213-220 (1999).
Grasso et al., “Peripheral Administration of Leptin-Related Synthetic Peptide Amides Corresponding to Residues 21 to 65 of Mouse Leptin has No Effect on Food Intake or Body Weight in Female C57BL/6Job/obMice”, 1997 Eastern Great Lakes Endocrin Symposium, Albany, NY Poster Abstract, Nov. 3, 1997.
Grasso et al., “Intraperitoneal Administration of Leptin-Related Synthetic Peptide Amides Corresponding to Amino Acid Residues 21 to 65 of Mouse Leptin Has No Effect on Food Intake or Body Weight Gain in Female C57BL/6Job/obMice”, in 80th Annual Meeting of the Endocrine Society, Poster Abstract, (1998).
Grasso et al., “Synthetic Leptin-Related Peptide 116-130 Reduces Food Intake and Body Weight Gain in Female C57BL/6Job/obMice by Mechanisms Independent of Peptide Activation of OB-R”, 81st Annual Meeting of the Endocrine Society, San Diego CA., Post Abstract, (Jun. 12-15, 1999).
Grasso et al., “Epitope mapping of secreted mouse leptin utilizing peripherally administered synthetic peptides”,Regulatory Peptides, 85(23):93-100 (1999).
Grasso et al., “In Vivo Effects of Follicle-Stimulating Hormone-Related Synthetic Peptides on the Mouse Estrous Cycle”,Endocrinol., 137(12):5370-5375 (1991).
Grasso et al., “In Vivo Effects of Leptin-Related Synthetic Peptides on Body Weight and Food Intake in Femaleob/obMice: Localization of Leptin Activity to Domains Between Amino Acid Residues 106-140”,Endocrinol., 138(4):1413-1418 (1997).
Grasso et al., “Inhibitory Effects of Leptin-Related Synthetic Peptide 116-130 on Food Intake and Body Weight Gain in Fe
Grasso Patricia
Lee Daniel W.
Leinung Matthew C.
Albany Medical College
Chandra Gyan
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
LandOfFree
Isolated antibodies against biologically active... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolated antibodies against biologically active..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolated antibodies against biologically active... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4280466